Subscribe to Newsletter

Carol Lynch

The Power List 2018 – Industry Influencers

Carol Lynch

President Sandoz Inc and Head of North America

Carol is currently Global Head of Biopharmaceuticals at Sandoz – a business she has successfully managed since September 2014. During this time the business grew rapidly, reached $1 billion in sales annually, and the portfolio came to fruition with 5 biosimilar approvals. Under Carol’s leadership, Sandoz achieved the first approval and launch of a biosimilar in the US, and last year saw the launch of the next wave of biosimilars in the EU. With the recent announcement of Sandoz’s collaboration with Biocon, the company has further strengthened its pipeline. Effective March 1, Carol Lynch succeeded Peter Goldschmidt.

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine